Stay updated on INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Sign up to get notified when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No significant changes were detected on the Study Details page for NCT03673501. The content, locations, and eligibility criteria appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T09:56:56.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    - Updated version to v3.2.0 and removed the Gastrointestinal stromal tumor resource from Genetic and Rare Diseases Information Center. - Added a government funding lapse notice with operating-status guidance for users.
    Difference
    2%
    Check dated 2025-10-05T14:29:41.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0 to reflect a newer release.
    Difference
    0.1%
    Check dated 2025-09-28T09:48:49.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Update to Revision: v3.0.2 from v3.0.1; removal of 'Back to Top' is a minor UI change and does not affect core content.
    Difference
    0.1%
    Check dated 2025-09-14T00:16:45.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T21:00:59.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as detailed references to recent studies on gastrointestinal stromal tumors and the drug ripretinib, while removing some previous location terms and outdated references.
    Difference
    15%
    Check dated 2025-08-30T15:27:56.000Z thumbnail image

Stay in the know with updates to INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRIGUE: Ripretinib vs Sunitinib in GIST Clinical Trial page.